F

Fulgent Genetics

FLGT

23.580
USD
-0.41
(-1.71%)
Market Open
Volume
3,935
EPS
0
Div Yield
0
P/E
-4
Market Cap
651,378,663
Related Instruments
C
CDNA
3.680
(18.46%)
23.610 USD
C
CGEN
0.05000
(2.84%)
1.81000 USD
E
EXAS
12.150
(26.55%)
57.910 USD
G
GH
-1.770
(-5.04%)
33.380 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
N
NVTA
0
(0%)
0.000000 USD
REGN
13.14
(1.22%)
1,091.19 USD
T
TDOC
-0.85000
(-9.00%)
8.59000 USD
TMO
9.03
(1.47%)
621.78 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Title: Fulgent Genetics

Sector: Healthcare
Industry: Diagnostics & Research
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.